EXSIGHT VENTURES
  • Home
  • Companies
  • Team
  • Blog
  • Contact
  • Thesis

Portfolio Companies

Picture
 Re-Vana Therapeutics, Ltd. | Belfast, Northern Ireland
 Developing state of the art long acting biodegradable drug delivery platform
 News:  Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing
              Dr. Rahhal Interview Re-Vana Therapeutics, Ltd. CEO Michael O'Rourke

Picture
LensGen, Inc. | Irvine, California
A biomimetic accommodating intraocular lens
News:   LENSGEN® Announces Presentations and SCIENTIFIC Papers AT ESCRS
              LensGen Updates on Juvene IOL, adds $15m to Series A

Picture
 Envision Diagnostics, Inc. | Los Angeles, California
 Revolutionizing the eye exam
  News: Envision Diagnostics raises Series A Financing
                                                      Publication:
  Automated Pupillometry Using a Prototype Binocular Optical Coherence Tomography System

Picture
 DTx Pharma. | San Diego, California
 Enabling precision medicine by unlocking oligonucleuotide therapeutics.
 News:  DTx Pharma Completes $10.6 Million Series A Financing

Picture
ONL Therapeutics, Inc. | Ann Arbor, Michigan
Pioneering an entirely new approach to preserving sight
News:   ONL Therapeutics Announces First Patient Treated in Phase I Study With ONL1204
               ONL Therapeutics Announces First-in-human Clinical Study With ONL1204
               ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 


Picture
Trefoil Therapeutics, Inc. | San Diego, California
Developing novel compounds to treat corneal dystrophies
News:  Trefoil Therapeutics Appoints Thomas M. Tremblay, RN BSN, Vice President,             Clinical Development
                  Trefoil Therapeutics Raises $5.2 Million Series 1 Financing 

                 

Picture
 2C Tech Corporation, Inc. | Irvine, California
 Quantum Dots to treat retinal disease 
Studies:
  Library

Picture
  Qura, Inc. | Boston, Massachusetts
  Implantable intraocular pressure sensor 
  News:  Qura receives strategic investment from Santen Ventures

Picture
RetroSense Therapeutics, LLC | Irvine, California
(Acquired: Allergan) First in class optogenetics therapy to treat retinal diseases 
News:  Allergan Acquires Gene Therapy Company RetroSense Therapeutics 

 ©ExSight Ventures, LLC                    Privacy Policy                    Terms and Conditions          Disclaimer       
  • Home
  • Companies
  • Team
  • Blog
  • Contact
  • Thesis